Annual CFO
-$8.03 M
-$230.90 K-2.96%
December 1, 2023
Summary
- As of February 8, 2025, CELZ annual cash flow from operations is -$8.03 million, with the most recent change of -$230.90 thousand (-2.96%) on December 1, 2023.
- During the last 3 years, CELZ annual CFO has fallen by -$7.59 million (-1747.19%).
- CELZ annual CFO is now -729909.09% below its all-time high of $1100.00, reached on December 1, 2006.
Performance
CELZ Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$985.60 K
+$483.70 K+32.92%
September 1, 2024
Summary
- As of February 8, 2025, CELZ quarterly cash flow from operations is -$985.60 thousand, with the most recent change of +$483.70 thousand (+32.92%) on September 1, 2024.
- Over the past year, CELZ quarterly CFO has dropped by -$88.70 thousand (-9.89%).
- CELZ quarterly CFO is now -1829.12% below its all-time high of $57.00 thousand, reached on December 1, 2020.
Performance
CELZ Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$5.25 M
+$318.90 K+5.73%
September 1, 2024
Summary
- As of February 8, 2025, CELZ TTM cash flow from operations is -$5.25 million, with the most recent change of +$318.90 thousand (+5.73%) on September 1, 2024.
- Over the past year, CELZ TTM CFO has dropped by -$163.70 thousand (-3.22%).
- CELZ TTM CFO is now -124823.81% below its all-time high of -$4200.00, reached on March 1, 2008.
Performance
CELZ TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CELZ Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.0% | -9.9% | -3.2% |
3 y3 years | -1747.2% | +37.5% | -56.6% |
5 y5 years | -662.9% | +37.5% | -56.6% |
CELZ Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -262.3% | at low | -12.9% | +74.3% | -136.8% | +47.9% |
5 y | 5-year | -1747.2% | at low | -1829.1% | +74.3% | -1107.5% | +47.9% |
alltime | all time | <-9999.0% | at low | -1829.1% | +74.3% | <-9999.0% | +47.9% |
Creative Medical Technology Holdings Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$985.60 K(-32.9%) | -$5.25 M(-5.7%) |
Jun 2024 | - | -$1.47 M(+63.8%) | -$5.57 M(+9.5%) |
Mar 2024 | - | -$896.90 K(-52.7%) | -$5.08 M(-36.7%) |
Dec 2023 | -$8.03 M(+3.0%) | -$1.90 M(+45.3%) | -$8.03 M(-17.4%) |
Sep 2023 | - | -$1.30 M(+32.2%) | -$9.72 M(+4.6%) |
Jun 2023 | - | -$986.70 K(-74.3%) | -$9.29 M(-7.6%) |
Mar 2023 | - | -$3.84 M(+7.0%) | -$10.06 M(+29.0%) |
Dec 2022 | -$7.80 M(+251.9%) | -$3.59 M(+311.2%) | -$7.80 M(+45.3%) |
Sep 2022 | - | -$873.30 K(-50.3%) | -$5.37 M(+9.9%) |
Jun 2022 | - | -$1.76 M(+11.3%) | -$4.88 M(+45.8%) |
Mar 2022 | - | -$1.58 M(+35.8%) | -$3.35 M(+51.2%) |
Dec 2021 | -$2.22 M(+409.8%) | - | - |
Dec 2021 | - | -$1.16 M(+197.2%) | -$2.22 M(+122.1%) |
Sep 2021 | - | -$390.80 K(+76.0%) | -$997.40 K(+27.8%) |
Jun 2021 | - | -$222.10 K(-49.7%) | -$780.60 K(+14.7%) |
Mar 2021 | - | -$441.50 K(-874.6%) | -$680.70 K(+56.7%) |
Dec 2020 | -$434.60 K(-64.2%) | $57.00 K(-132.8%) | -$434.50 K(-41.6%) |
Sep 2020 | - | -$174.00 K(+42.4%) | -$743.90 K(-19.9%) |
Jun 2020 | - | -$122.20 K(-37.4%) | -$928.20 K(-18.2%) |
Mar 2020 | - | -$195.30 K(-22.6%) | -$1.14 M(-6.4%) |
Dec 2019 | -$1.21 M(+15.3%) | -$252.40 K(-29.6%) | -$1.21 M(-3.4%) |
Sep 2019 | - | -$358.30 K(+8.8%) | -$1.26 M(+0.9%) |
Jun 2019 | - | -$329.40 K(+20.7%) | -$1.24 M(+7.3%) |
Mar 2019 | - | -$273.00 K(-7.6%) | -$1.16 M(+10.3%) |
Dec 2018 | -$1.05 M(+18.3%) | -$295.60 K(-14.8%) | -$1.05 M(+19.7%) |
Sep 2018 | - | -$346.90 K(+41.7%) | -$879.30 K(+9.1%) |
Jun 2018 | - | -$244.80 K(+48.5%) | -$806.10 K(-3.0%) |
Mar 2018 | - | -$164.90 K(+34.4%) | -$830.80 K(-6.6%) |
Dec 2017 | -$889.60 K(+99.8%) | -$122.70 K(-55.2%) | -$889.60 K(-6.6%) |
Sep 2017 | - | -$273.70 K(+1.6%) | -$952.30 K(+19.1%) |
Jun 2017 | - | -$269.50 K(+20.5%) | -$799.50 K(+26.2%) |
Mar 2017 | - | -$223.70 K(+20.7%) | -$633.30 K(+42.2%) |
Dec 2016 | -$445.20 K | -$185.40 K(+53.3%) | -$445.30 K(+70.1%) |
Sep 2016 | - | -$120.90 K(+17.0%) | -$261.80 K(+82.7%) |
Jun 2016 | - | -$103.30 K(+189.4%) | -$143.30 K(+219.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | -$35.70 K(+1778.9%) | -$44.90 K(+207.5%) |
Dec 2015 | -$14.60 K(-15.6%) | -$1900.00(-20.8%) | -$14.60 K(-18.9%) |
Sep 2015 | - | -$2400.00(-51.0%) | -$18.00 K(-1.6%) |
Jun 2015 | - | -$4900.00(-9.3%) | -$18.30 K(-2.1%) |
Mar 2015 | - | -$5400.00(+1.9%) | -$18.70 K(+7.5%) |
Dec 2014 | -$17.30 K(-24.5%) | -$5300.00(+96.3%) | -$17.40 K(+6.1%) |
Sep 2014 | - | -$2700.00(-49.1%) | -$16.40 K(-5.7%) |
Jun 2014 | - | -$5300.00(+29.3%) | -$17.40 K(-3.3%) |
Mar 2014 | - | -$4100.00(-4.7%) | -$18.00 K(-21.4%) |
Dec 2013 | -$22.90 K(+36.3%) | -$4300.00(+16.2%) | -$22.90 K(+5.0%) |
Sep 2013 | - | -$3700.00(-37.3%) | -$21.80 K(-1.4%) |
Jun 2013 | - | -$5900.00(-34.4%) | -$22.10 K(+17.6%) |
Mar 2013 | - | -$9000.00(+181.3%) | -$18.80 K(+11.9%) |
Dec 2012 | -$16.80 K(+20.0%) | -$3200.00(-20.0%) | -$16.80 K(+22.6%) |
Sep 2012 | - | -$4000.00(+53.8%) | -$13.70 K(-8.1%) |
Jun 2012 | - | -$2600.00(-62.9%) | -$14.90 K(-13.4%) |
Mar 2012 | - | -$7000.00(+6900.0%) | -$17.20 K(+23.7%) |
Dec 2011 | -$14.00 K(+2.2%) | -$100.00(-98.1%) | -$13.90 K(-16.3%) |
Sep 2011 | - | -$5200.00(+6.1%) | -$16.60 K(-4.0%) |
Jun 2011 | - | -$4900.00(+32.4%) | -$17.30 K(+39.5%) |
Mar 2011 | - | -$3700.00(+32.1%) | -$12.40 K(-9.5%) |
Dec 2010 | -$13.70 K(-55.4%) | -$2800.00(-52.5%) | -$13.70 K(-34.1%) |
Sep 2010 | - | -$5900.00(<-9900.0%) | -$20.80 K(+3.0%) |
Jun 2010 | - | $0.00(-100.0%) | -$20.20 K(-43.3%) |
Mar 2010 | - | -$5000.00(-49.5%) | -$35.60 K(+15.6%) |
Dec 2009 | -$30.70 K(-46.3%) | -$9900.00(+86.8%) | -$30.80 K(-0.6%) |
Sep 2009 | - | -$5300.00(-65.6%) | -$31.00 K(-50.2%) |
Jun 2009 | - | -$15.40 K(+7600.0%) | -$62.20 K(+17.1%) |
Mar 2009 | - | -$200.00(-98.0%) | -$53.10 K(-7.0%) |
Dec 2008 | -$57.20 K(+343.4%) | -$10.10 K(-72.3%) | -$57.10 K(+21.5%) |
Sep 2008 | - | -$36.50 K(+479.4%) | -$47.00 K(+347.6%) |
Jun 2008 | - | -$6300.00(+50.0%) | -$10.50 K(+150.0%) |
Mar 2008 | - | -$4200.00 | -$4200.00 |
Dec 2007 | -$12.90 K(-1272.7%) | - | - |
Dec 2006 | $1100.00 | - | - |
FAQ
- What is Creative Medical Technology Holdings annual cash flow from operations?
- What is the all time high annual CFO for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings annual CFO year-on-year change?
- What is Creative Medical Technology Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings quarterly CFO year-on-year change?
- What is Creative Medical Technology Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Creative Medical Technology Holdings?
- What is Creative Medical Technology Holdings TTM CFO year-on-year change?
What is Creative Medical Technology Holdings annual cash flow from operations?
The current annual CFO of CELZ is -$8.03 M
What is the all time high annual CFO for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high annual cash flow from operations is $1100.00
What is Creative Medical Technology Holdings annual CFO year-on-year change?
Over the past year, CELZ annual cash flow from operations has changed by -$230.90 K (-2.96%)
What is Creative Medical Technology Holdings quarterly cash flow from operations?
The current quarterly CFO of CELZ is -$985.60 K
What is the all time high quarterly CFO for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high quarterly cash flow from operations is $57.00 K
What is Creative Medical Technology Holdings quarterly CFO year-on-year change?
Over the past year, CELZ quarterly cash flow from operations has changed by -$88.70 K (-9.89%)
What is Creative Medical Technology Holdings TTM cash flow from operations?
The current TTM CFO of CELZ is -$5.25 M
What is the all time high TTM CFO for Creative Medical Technology Holdings?
Creative Medical Technology Holdings all-time high TTM cash flow from operations is -$4200.00
What is Creative Medical Technology Holdings TTM CFO year-on-year change?
Over the past year, CELZ TTM cash flow from operations has changed by -$163.70 K (-3.22%)